BRAIN
	BREAST
	GASTROINTESTINAL
	GENITOURINARY
	GYNECOLOGICAL
	HEAD AND NECK
	LUNG

	0627 - PHASE II TRIAL OF DASATINIB IN PATIENTS WITH RECURRENT GLIOBLASTOMA MULTIFORME
	0320 - A PHASE III TRIAL COMPARING WHOLE brain RADIATION AND STEROTACTIC RADIOSURGERY ALONE VERSUS WITH TEMOZOLOMIDE OR ERLOTINIB IN PATIENTS WITH NON-SMALL CELL LUNG CANCER AND 1-3 BRAIN METASTASES

	B-39/0413 - A Randomized Phase III Study of Conventional Whole Breast Irradiation (WBI) Versus Partial Breast Irradiation (PBI) for Women with Stage 0, I, or II Breast Cancer
	pacct-1 - Program for the Assessment of Clinical Cancer Tests (PACCT-1): Trial Assigning IndividuaLized Options for Treatment: The TAILORx Trial
	B-44-I (BETH) - A MULTICENTER PHASE III RANDOMIZED TRIAL OF ADJUVANT THERAPY FOR PATIENTS WITH HER2-POSITIVIE NODE NEGATIVE OR HIGH RISK NODE-NEGATIVE BREAST CANCER COMPARING CHEMOTHERAPY PLUS TRASTUZUMAB WITH CHEMOTHERAPY PLUS TRASTUZUMAB PLUS BEVACIZUMAB
	E2Z04 - quality OF LIFE IN YOUNGER BREAST CANCER SURVIVORS

0436 - A Phase III Trial Evaluating the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation for Patients with Esophageal Cancer Who Are Treated Without Surgery

80405 - A Phase III Trial of Irinotecan/5-FU/Leucovorin or Oxaliplatin/5-FU/Leucovorin with Bevacizumab, or Cetuximab (C225), or with the Combination of Bevacizumab and Cetuximab for Patients with Untreated Metastatic Adenocarcinoma of the Colon or Rectum

RECTAL

0822 - A PHASE II EVALUATION OF PREOPERATIVE CHEMORADIOTHERAPY UTILIZING INTENSITY MODULATED RADIATION THERAPY (IMRT) IN COMBINATION WITH CAPECITABINE AND OXALIPLATIN FOR PATIENTS WITH LOCALLY ADVANCED RECTAL CANCER

Back to Top

E2805 -  A Randomized, Double-Blind Phase III Trial of Adjuvant Sunitinib versus Sorafenib versus Placebo in Patients with Resected Renal Cell Carcinoma

0518 - A Phase III, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Zometa® for the Prevention of Osteoporosis and Associated Fractures in Patients Receiving Radiation Therapy and Long Term LHRH Agonists for High-Grade and/or Locally Advanced Prostate Cancer

E1505 - a phase iii randomized trial of adjuvant chemotherapy with or without bevacizumab for patIents with completely resected stage ib (> 4 CM) -IIIA NON-SMALL CELL LUNG CANCER (NSCLC)